Spark Therapeutics' Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Mark Terry… Source: BioSpace You Might Also Like AbbVie Declares Quarterly Dividend February 19, 2017 Regulus Announces Pricing Of Public Offering Of Common Stock July 19, 2017 Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017
Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017
